What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Cancer
Her primary areas of study are Internal medicine, Endocrinology, OGFr, Endogenous opioid and Naltrexone.
Her Internal medicine research is multidisciplinary, incorporating elements of Offspring and Gestation.
Her Endocrinology study combines topics from a wide range of disciplines, such as Receptor, Opioid peptide, Autocrine signalling and Opioid.
Her biological study spans a wide range of topics, including Corneal epithelium, Cancer research, Cell growth, Growth factor and Cell biology.
Her work deals with themes such as Opioid receptor and Enkephalin, which intersect with Endogenous opioid.
Her Naltrexone study incorporates themes from -Naloxone, Opioid antagonist, Pharmacology and Opiate.
Her most cited work include:
- The biology of the opioid growth factor receptor (OGFr). (250 citations)
- Increased brain size and cellular content in infant rats treated with an opiate antagonist (203 citations)
- Naltrexone modulates tumor response in mice with neuroblastoma (182 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Internal medicine, Endocrinology, OGFr, Naltrexone and Endogenous opioid.
Patricia J. McLaughlin combines subjects such as -Naloxone, Opioid receptor, Opioid, Enkephalin and Gestation with her study of Endocrinology.
Her study looks at the relationship between OGFr and fields such as Cell growth, as well as how they intersect with chemical problems.
The study incorporates disciplines such as Anesthesia, Opioid antagonist and Pharmacology in addition to Naltrexone.
Her research in Endogenous opioid intersects with topics in Endorphins and Neuroblastoma.
Her studies in Opioid peptide integrate themes in fields like Corneal epithelium and Autocrine signalling.
She most often published in these fields:
- Internal medicine (51.63%)
- Endocrinology (49.26%)
- OGFr (48.66%)
What were the highlights of her more recent work (between 2012-2021)?
- OGFr (48.66%)
- Naltrexone (29.67%)
- Multiple sclerosis (5.64%)
In recent papers she was focusing on the following fields of study:
OGFr, Naltrexone, Multiple sclerosis, Internal medicine and Pharmacology are her primary areas of study.
Her research integrates issues of Blockade, Endogenous opioid and Enkephalin in her study of OGFr.
Her Naltrexone research incorporates elements of Anesthesia, Diabetes mellitus, Type 2 diabetes, Ophthalmology and Opioid receptor.
The concepts of her Internal medicine study are interwoven with issues in Endocrinology and Oncology.
Her study in Endocrinology is interdisciplinary in nature, drawing from both Cell cycle and Growth factor receptor.
Her work carried out in the field of Pharmacology brings together such families of science as Corneal topography, Opioid antagonist, Angiogenesis and DNA synthesis.
Between 2012 and 2021, her most popular works were:
- Duration of opioid receptor blockade determines biotherapeutic response (33 citations)
- Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis. (30 citations)
- Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer. (26 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
Her main research concerns OGFr, Naltrexone, Low-dose naltrexone, Pharmacology and Experimental autoimmune encephalomyelitis.
The various areas that Patricia J. McLaughlin examines in her OGFr study include Endocrinology and Cell growth.
Her Naltrexone study combines topics in areas such as Ophthalmology, Ocular surface, Anesthesia and Opioid antagonist.
While the research belongs to areas of Opioid antagonist, Patricia J. McLaughlin spends her time largely on the problem of Opioid receptor, intersecting her research to questions surrounding κ-opioid receptor and -Naloxone.
Her study explores the link between Pharmacology and topics such as DNA synthesis that cross with problems in Ovarian cancer, Ovarian cancer cells, Met5 enkephalin, Biological pathway and Blood vessel.
Her research on Internal medicine often connects related areas such as Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
